Pubblicazioni

Leader in Italia nella ricerca e nella
commercializzazione di kit diagnostici
per test farmacogenetici

108, 2015

Andrea Imperatori et al., Durable recurrence-free survival after pneumonectomy for late lung metastasis from rectal cancer: case report with genetic and epigenetic analyses. BMC Cancer

2807, 2015

Veronica Villani, Beatrice Casini, Andrea Pace, et al., “The Prognostic Value of Pyrosequencing-Detected MGMT Promoter Hypermethylation in Newly Diagnosed Patients with Glioblastoma,” Disease Markers, vol. 2015, Article ID 604719, 6 pages, 2015. doi:10.1155/2015/604719

307, 2015

Maria Teresa Voso et al., Fanconi anemia gene variants in therapy-related myeloid neoplasms. Blood Cancer Journal

906, 2015

Marta Schirippa et al., BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection. British Journal of Cancer

806, 2015

Hauck, F., Oliveira-Silva, M., Dreyer, J.H. et al. Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany. Virchows Arch (2015) 466: 685.

806, 2015

Lo Dico, A., Martelli, C., Valtorta, S. et al. Identification of imaging biomarkers for the assessment of tumour response to different treatments in a preclinical glioma model. Eur J Nucl Med Mol Imaging (2015) 42: 1093.

705, 2015

Corrado Iaccarino et al., Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy. Clinical Neurology and Neurosurgery

705, 2015

Riccardo Giampieri et al., Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab. Journal of Translational Medicine

105, 2015

Chiara Colato et al., Break–apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements. European Journal of Endocrinology

604, 2015

Mariani S, Di Bello C, Bonello L, Tondat F, Pacchioni D, Molinaro L, et al. (2015) Flexible Lab-Tailored Cut-Offs for Suitability of Formalin-Fixed Tumor Samples for Diagnostic Mutational Analyses. PLoS ONE 10(4): e0121815.

604, 2015

Daniela Massi et al., Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma. Modern Pathology

104, 2015

Giovanna De Maglio et al., MGMT promoter methylation status in brain metastases from colorectal cancer and corresponding primary tumors. Future Oncology

Precedente 303132 Successivo

Pubblicazioni

Leader in Italia nella ricerca e nella
commercializzazione di kit diagnostici
per test farmacogenetici

Cerca pubblicazione

Filtra per anno

Cerca per primo autore

Cerca per linea

Pubblicazioni

Leader in Italia nella ricerca e nella commercializzazione di kit diagnostici per test farmacogenetici

Cerca pubblicazione

Filtra per anno

Cerca per primo autore

Cerca per linea

Leader in Italia nella ricerca e nella
commercializzazione di kit diagnostici
per test farmacogenetici